Evidence map›Paper›PMID 40269784›Full record

ArticleBMC cancer2025

Primary and postoperative radiotherapy in acute neurological symptoms due to malignant spinal compression: retrospective analysis from a German university hospital.

Manuel Guhlich, Teresa Esther Maag, Markus Anton Schirmer, Tatiana Andrea Chacón Quesada, Dorothee Mielke, Stefan Rieken, Martin Leu, Leif Hendrik Dröge

Abstract read
In one paragraph

Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Manuel Guhlich *Clinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany. manuel.guhlich@med.uni-goettingen.de.
Teresa Esther Maag *Clinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Markus Anton SchirmerClinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Tatiana Andrea Chacón QuesadaDepartment of Neurological Surgery, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Dorothee MielkeDepartment of Neurological Surgery, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Stefan RiekenClinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Martin Leu *Clinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.
Leif Hendrik Dröge *Clinic of Radiotherapy and Radiation Oncology, University Medical Center Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant spinal cord compression (MSCC) can lead to immediate neurological impairment. In order to preserve and, optimally, restore neurological functions, urgent treatment (usually, within 24 h) is necessary. Treatment options mainly consist of decompressive surgery (DS) and / or radiotherapy (RT) combined with steroids. Whereas historically, RT was the treatment of choice, DS has become standard of care, where applicable. Despite a variety of excellent studies, real world data of treatment in a large academic center is currently underrepresented. We performed a retrospective analysis of patients treated for MSCC in our department of radiotherapy between 1998 and 2018 (n = 131), evaluating treatment, achievement of clinically determined improvement of neurological functions as well as overall survival (OS) and treatment-related toxicity. Kaplan-Meier estimator was used for survival statistics, log rank test for survival time comparisons, univariable and multivariable Cox regression and logistic regression for assessing potential impacts of variables on survival and symptom relief. 42.7% of patients had DS before RT (n = 56), 57.3% (n = 75) received RT without DS. Symptom relief was achieved in 41.2% of all patients (n = 54, n = 26 of those had DS before RT, p = 0.12). RT completed as intended (p < 0.001) was statistically significant for symptom relief, wherein symptom relief (p < 0.001), completion of RT course as intended (p = 0.01) and more recent treatment dates (p = 0.002) were independent predictors for OS. We herein present a large cohort of patients treated for MSCC in our academic center, representing real world treatment data currently lacking in literature.

Indexed as

Spinal Cord CompressionSpinal NeoplasmsAdultAgedAged, 80 and overDecompression, SurgicalFemaleGermanyHospitals, UniversityHumansKaplan-Meier EstimateMaleMiddle AgedRetrospective StudiesTreatment OutcomeAcute neurologyBone metastasisEmergency radiation therapyMetastatic spinal cord compressionMSCCRadiation therapyRadiotherapyRetrospective analysisSCCSpinal cord compression

Identifiers

PMID40269784
PMCPMC12016431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.